Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Nature Materials|July 16, 2008
Resonant bonding in crystalline phase-change materialsKostiantyn Shportko, Stephan Kremers, Michael Woda, et al.Cancer|February 14, 2017
Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature deathMichael Lauseker, Joerg Hasford, Susanne Saussele, et al.Annals of Hematology|September 15, 2017
Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III studyMartin Kropff, Martin Vogel, Guido Bisping, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2010
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33)Sibylle Loibl, Volkmar Mueller, Gunter von Minckwitz, et al.Leukemia & Lymphoma|August 22, 2015
Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study GroupValentin Goede, Raymonde Busch, Jasmin Bahlo, et al.Annals of Hematology|March 8, 2024
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study GroupGabriel Scheubeck, Martin Hoffmann, Vindi Jurinovic, et al.Blood|September 16, 2011
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphomaBoris Böll, Henning Bredenfeld, Helen Görgen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98ARichard F Schlenk, Konstanze Döhner, Silja Mack, et al.The Lancet. Oncology|April 17, 2012
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trialRalf-Dieter Hofheinz, Frederik Wenz, Stefan Post, et al.Annals of Hematology|March 25, 2014
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IVUlrike Proetel, Nadine Pletsch, Michael Lauseker, et al.Pageof 2